Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties. Using the approach, scientists exchanged one chemical group for another in 39 cancer drugs—and discovered under lab conditions that the chemically altered versions of three of the drugs had more potent anti-cancer activity.
The results, published today in the Journal of the American Chemical Society, reveal a powerful application of so-called “click chemistry” to drug discovery.
“Usually you have to make thousands or millions of molecules and go through a big screening process to find one or two molecules that are interesting and might work,” says Peng Wu, PhD, a TSRI associate professor and one of the study’s lead authors. “With this new approach, you can save time and money by starting with drugs and molecules you know are already active and asking whether a quick modification makes any of them any better.”
“Our results suggest we will be able take a drug and make it more potent, faster acting, and hopefully with better bioavailability,” adds Nobel laureate K. Barry Sharpless, PhD, who co-led the study.
Sharpless, the TSRI W.M. Keck Professor of Chemistry, first conceived of click chemistry in the 1990s. Click chemistry is the term for simple molecular reactions that can each be carried out in one container, undisturbed by water, and generate just one stable product at high yield. Sharpless compares the method to decorating molecules like Christmas trees, adding a new functional “ornament” to one of a molecule’s branches, which he calls “clickable hubs.”
“Instead of pursuing leads, which is the traditional method, SuFEx click chemistry is about connecting promising drug candidates directly with targets,” says Sharpless.
One of the latest click chemistry reactions developed by Sharpless’ group was Sulfur (VI) Fluoride Exchange (SuFEx), which transforms any phenol chemical group into a fluorosulfate. Because fluorosulfates have some benefits over phenols—including tighter binding to proteins, and less ability to be modified in the cell—the SuFEx reaction offers a way to potentially improve phenol drugs.
However, the transformation typically relies on sulfuryl fluoride gas, which makes it hard to perform on many different molecules at the same time; each reaction must be carried out in its own flask.
In the new paper, Sharpless and Wu show that sulfuryl fluoride gas can be dissolved in an organic solvent to make a liquid form of the reagent needed for SuFEx. “Now, suddenly, we can use this in high-throughput experiments,” says Wu.
To test the reaction’s utility in drug discovery, Sharpless, Wu and their colleagues put 39 existing cancer drugs containing phenols into plates, added the liquid version of sulfuryl fluoride to each well, and exposed cancer cells to both the original compounds and the resulting fluorosulfate versions. In three instances, the new fluorosulfate drug killed more cancer cells than the original version. When modified with SuFEx, the breast cancer drug Fulvestrant had a great effect on estrogen receptors in breast cancer cells, and the cancer drug Combretastatin A4 was 70 times more potent against colon cancer cells.
Upon further examination, the researchers discovered that the new molecules bound to their molecular targets better and were less apt to be metabolized by the cells.
“We think our approach is generally applicable to drug modification outside of just cancer drugs,” says Wu. The team is already using the new high-throughput SuFEx to modify drugs targeting the immune system’s T cells, he adds.
Learn more: ‘Click chemistry’ reactions may boost cancer-fighting drug potency
The Latest on: Click chemistry
via Google News
The Latest on: Click chemistry
- "If You Don't Shoot the Arrow, It Doesn't Hit the Target"--Interview with WPI-MANA Researcheron November 23, 2020 at 9:24 pm
Many people who read my paper called the material a 'tsukemono chodendo-tai,' meaning pickled superconductor." Q: You are famous for discovering a new superconductor using red wine. What made you ...
- Trick Your Kids Into Learning Science With This Awesome Chemistry Set Subscription Serviceon November 23, 2020 at 1:11 pm
Of course, chemistry sets have obviously been around for a long time. You probably had one when you were a kid. Your parents probably had one, too. And you can still get them today. But the science ...
- Texas A&M Chemist Quentin Michaudel Earns Coveted NIH Research Awardon November 23, 2020 at 11:19 am
Congratulations to Texas A&M chemist Quentin Michaudel, selected to receive a $1.8 million National Institutes of Health Maximizing Investigators' Research Award (MIRA) to support his group's research ...
- Immunotherapy, The Most Prominent Topic In Skin Cancer Researchon November 22, 2020 at 11:52 pm
A report published on May 21 2019 highlights the different research areas in the field of skin cancer showing that immunotherapy is the most prominent topic and reveals the countries that are driving ...
- UCF basketball quickly developing chemistry despite pandemicon November 18, 2020 at 7:44 am
UCF basketball coach Johnny Dawkins and his players say they are quickly forging tight bonds despite offseason coronavirus isolation and are looking forward to playing a tough nonconference slate.
- From click chemistry to antibiotic spider silkon November 9, 2020 at 4:00 pm
Antimicrobial activity can be maintained for at least five days. The Nottingham research team has shown for the first time how so-called click chemistry can be used to attach molecules, such as ...
- Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Programon October 29, 2020 at 10:42 am
Mejia Oneto, M.D., Ph.D., Founder and CEO of Shasqi. The CAPAC Platform is a new therapeutic modality based on click chemistry, which leverages biocompatible chemical reactions, to activate ...
- Chelsea lack chemistry but Ziyech, Werner and Havertz show they will be lethal when they clickon October 28, 2020 at 1:33 pm
CHELSEA still lack chemistry but Hakim Ziyech, Timo Werner and Kai Havertz showed during the 4-0 cruise in Krasnodar they will be lethal when they click. Boss Frank Lampard spent vast sums of ...
- Click chemistry sees first use in humanson October 21, 2020 at 6:00 pm
Chemistry matters. Join us to get the news you need. Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are ...
- Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Programon October 14, 2020 at 6:59 am
Mejía Oneto, M.D., Ph.D., Founder and CEO of Shasqi. The CAPAC Platform is a new therapeutic modality based on click chemistry, which leverages biocompatible chemical reactions, to activate ...
via Bing News